Shares shifted sharply as Lemonade dropped 7% to $57.78 in pre-market trading after its second-quarter 2026 results landed before the bell. The AI-powered insurer delivered $294.4 million in revenue — up 79% year-over-year and slightly above the $291.5 million Wall Street consensus — yet posted an EPS loss of ($0.56), roughly in line with estimates. Analysts had expected about $291.52 million in revenue and an EPS loss around ($0.52). The message from the market: top-line fireworks aren't enough when losses keep coming.

  • Revenue Beat Masks a Reinsurance Tailwind That's Fading. Much of Lemonade's headline growth is turbocharged by a structural shift: the company is keeping more of its own insurance premiums instead of passing them to reinsurers. The company reduced its reinsurance cession from 20% to 18%, reflecting growing confidence in its AI underwriting models.

That lower rate of ceded premiums is currently propping up revenue growth. Once that transition normalizes — management said it would settle near 20% by Q3 — revenue growth will slow to a rate closer to its underlying premium growth of around 32%. Investors who bought the 79% headline may be repricing that reality today.

  • Losses Keep Stacking Even as the Business Scales. The ($0.56) EPS loss was wider than Q1's ($0.47) result. Operating expenses increased by 25% year-over-year, driven by higher sales and marketing expenses.

Q2 gross marketing spend stepped up roughly 12% versus Q1, with total gross spend expected at about $235 million for 2026. Management is spending aggressively to grow, and that spend is not yet translating into bottom-line improvement quarter to quarter.

  • The Profitability Promise Faces a Credibility Test. Lemonade raised its full-year guidance and reiterated that it expects to deliver a positive full quarter of adjusted EBITDA (earnings before interest, taxes, depreciation, and stock compensation) in Q4 2026 and be EBITDA-positive for the full year 2027. But the stock is down 29% since January, suggesting patience is wearing thin. Lemonade trades at a price-to-sales ratio of roughly 5.1x, compared with 1.1x for the broader U.S. insurance sector, a premium that only holds if profitability materializes on schedule.

  • Improved Underwriting Is Real, But Not Enough to Calm Nerves. The company's gross loss ratio — claims costs relative to earned premiums — dropped to 62% in Q1 2026 from 83% two years earlier, a genuine sign that AI-driven pricing is working. Yet today's selloff shows investors want proof of profit, not just proof of concept.